Month: May 2012

Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®

This is a study required by the FDA to determine if Egrifta use in HIV+ people with diabetes can increase the risks of diabetic retinopathy. https://clinicaltrials.gov/ct2/show/NCT01591902 Diabetic retinopathy  is a complication of diabetes that affects the eyes. It’s caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye …

Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA┬« Read More »

Looking for HIV+ Organ/Tissue Donors for Research

Facts about Organ and Tissue Donation for Research Requirements for research are different than requirements for transplant, and it is important to understand that anyone at any age may be a research donor candidate. A history of disease does not preclude donation for medical research. Scientists frequently need affected tissue in order to investigate treatments. …

Looking for HIV+ Organ/Tissue Donors for Research Read More »

HIV Cure Research: Flush-and-Kill Cancer Drug: SAHA or Vorinostat

Apr 23, 2012 What is SAHA and Vorinostat? is both are different? Response from Mr. Vergel SAHA (suberoylanilide hydroxamic acid) and Vorinostat are the same thing. Vorinostat was the first histone deacetylase inhibitor (HDAC) approved by the U.S. Food and Drug Administration (FDA) for the treatment of cutaneous T celllymphoma on October 6, 2006. It is …

HIV Cure Research: Flush-and-Kill Cancer Drug: SAHA or Vorinostat Read More »

Weight Loss Diets: High Protein Vs High Fiber

Studies have suggested that moderately high protein diets may be more appropriate than conventional low-fat high carbohydrate diets for individuals at risk of developing the metabolic syndrome and type 2 diabetes. However in most such studies sources of dietary carbohydrate may not have been appropriate and protein intakes may have been excessively high. Thus, in …

Weight Loss Diets: High Protein Vs High Fiber Read More »

Immune Cells Modified by Gene Therapy Survive After a Decade in HIV+ People

What an amazing study! They have followed HIV+ people that have had T cells modified by genetic engineering and given by transfusion once during the past 11 years of study . 41 of the 43 people were still healthy 11 years later.  Their modified T cells could still be found in their bodies. Modified T …

Immune Cells Modified by Gene Therapy Survive After a Decade in HIV+ People Read More »

New treatments for HIV associated lipodystrophy beyond Egrifta

Question from a person living with HIV: May 2, 2012 I body build and work out, eat right, etc. The lipodystrophy I accumulated during my early use of Crixivan and others doesn’t really go away that much. It’s frustrating, depressing. I do also appear to have some features of “muscle belly” where there is a space between …

New treatments for HIV associated lipodystrophy beyond Egrifta Read More »

Complementary Approaches to Treating Lipodystrophy

From the book: Built to Survive 12.  Complementary Approaches to Treating Lipodystrophy By Michael Mooney (original version in Medibolics 2(2),Nov. 1997) While the protease inhibitor (PI) cocktails can bring viral loads down to undetectable levels and have given many HIV(+) people a new lease on life, protease inhibitors are not always benign drugs. As we approach year …

Complementary Approaches to Treating Lipodystrophy Read More »